DrugPatentWatch Database Preview

J And J Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for J AND J, and what generic alternatives to J AND J drugs are available?

J AND J has thirty-three approved drugs.

There are four US patents protecting J AND J drugs.

There are forty-three patent family members on J AND J drugs in thirty-five countries and thirty-five supplementary protection certificates in thirteen countries.

Summary for J And J

International Patents:	43
US Patents:	4
Tradenames:	26
Ingredients:	13
NDAs:	33

Drugs and US Patents for J And J

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
J And J Consumer Inc	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET, CHEWABLE;ORAL	020606-001	Jun 26, 1996		DISCN	Yes	No
J And J Consumer Inc	SINE-AID IB	ibuprofen; pseudoephedrine hydrochloride	TABLET;ORAL	019899-001	Dec 31, 1992		OTC	No	No
J And J Consumer Inc	TYLENOL	acetaminophen	TABLET, EXTENDED RELEASE;ORAL	019872-001	Jun 8, 1994		OTC	Yes	Yes
J And J Consumer Inc	TYLENOL	acetaminophen	SUPPOSITORY;RECTAL	017756-001	Approved Prior to Jan 1, 1982		DISCN	No	No
J And J Consumer Inc	MOTRIN IB	ibuprofen	TABLET;ORAL	019012-003	Dec 17, 1990		OTC	Yes	No

Expired US Patents for J And J

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
J And J Consumer Inc	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET;ORAL	021140-001	Nov 30, 2000	6,103,260
J And J Consumer Inc	ZYRTEC-D 12 HOUR	cetirizine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021150-002	Nov 9, 2007	6,469,009
J And J Consumer Inc	PEPCID AC	famotidine	TABLET, CHEWABLE;ORAL	020801-001	Sep 24, 1998	5,667,794*PED
J And J Consumer Inc	IMODIUM A-D EZ CHEWS	loperamide hydrochloride	TABLET, CHEWABLE;ORAL	020448-001	Jul 24, 1997	5,489,436
J And J Consumer Inc	IMODIUM MULTI-SYMPTOM RELIEF	loperamide hydrochloride; simethicone	TABLET, CHEWABLE;ORAL	020606-001	Jun 26, 1996	5,612,054

Paragraph IV (Patent) Challenges for J AND J drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Chewable Tablets	5 mg and 10 mg		2005-03-25
	Syrup	5 mg/5 mL		2007-03-19
	Chewable Tablets	800 mg/ 10 mg/ 165 mg (OTC)		2004-11-01

International Patents for J And J Drugs

Country	Patent Number	Estimated Expiration
Hungary	229803
World Intellectual Property Organization (WIPO)	03002098
South Korea	20040007756
Costa Rica	7198
Romania	122476

Supplementary Protection Certificates for J And J Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2957286	1990003-4	Sweden		PRODUCT NAME: PATRIOMER SORBITEX CALCIUM; REG. NO/DATE: EU/1/17/1179 20170721
2435024	2021C/518	Belgium		PRODUCT NAME: UNE COMBINAISON DE FORMOTEROL (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES), GLYCOPYRROLATE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES) ET BUDESONIDE (Y COMPRIS TOUS SES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES); AUTHORISATION NUMBER AND DATE: EU/1/20/1498 20201210
0428296	SPC/GB98/013	United Kingdom		PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
2957286	122018000145	Germany		PRODUCT NAME: PATIROMER SORBITEX CALCIUM IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
0720599	CR 2014 00050	Denmark		PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• J And J
• J And J Consumer Inc